CN1572883A - Determination of specificity for a segment of ureaplasma DNA sequence and use thereof - Google Patents

Determination of specificity for a segment of ureaplasma DNA sequence and use thereof Download PDF

Info

Publication number
CN1572883A
CN1572883A CN 02133343 CN02133343A CN1572883A CN 1572883 A CN1572883 A CN 1572883A CN 02133343 CN02133343 CN 02133343 CN 02133343 A CN02133343 A CN 02133343A CN 1572883 A CN1572883 A CN 1572883A
Authority
CN
China
Prior art keywords
sequence
ureaplasma
segment
dna sequence
primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02133343
Other languages
Chinese (zh)
Inventor
谭德勇
朱宝生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd
Original Assignee
KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd filed Critical KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd
Priority to CN 02133343 priority Critical patent/CN1572883A/en
Publication of CN1572883A publication Critical patent/CN1572883A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a segment of urea decomposed mycoplasma DNA sequence specificity determination and use thereof, wherein gene data bank searching and analysis is conducted, the sequence length is 294bp, the specificity of the sequence to urea decomposed mycoplasma is confirmed.

Description

Segment of ureaplasma DNA sequence (3) is specific to be determined and application
Technical field:
The present invention relates to the specific definite and application of segment of ureaplasma (Ureaplasma urealyticum) dna sequence dna (3), belong to field of biomedicine technology.
Background technology:
Ureaplasma is the pathogen that a kind of human reproduction's device often infects, and can cause many urogenital tract diseases, and diagnosis accurately is to carry out the foundation of treatment immediately and reliably, can only diagnose according to clinical indication at present.PCR and gene chip diagnosis are a kind of rapid and precise detection methods.And the diagnostic method of this class depends on the special nucleotide sequence of acquisition.
Summary of the invention:
The invention reside in by information biology and Protocols in Molecular Biology, determined segment of ureaplasma specific nucleotide sequence and PCR primer thereof.This sequence can be used for setting up gene chip with corresponding PCR primer and PCR method is carried out the diagnosis of ureaplasma.
Technical scheme of the present invention is: the present invention utilizes existing method to determine segment of ureaplasma specific DNA sequence (3) and the PCR primer thereof of length for 294bp, carries out pcr amplification with primer, and its sequence is as follows:
atcccctgct?acacaacgag?cgattacacc?catttttaca?acataataag?gttttgcacc?60
aaagaattta?ggttctcaag?caacaatatc?agctaattta?ccaacttcta?gtgaaccaat?120
ataagaatca?acaccatgtg?caatagctgg?gttaatcgta?tatttagaaa?tataacgttt?180
tacacgattg?ttatcactga?attcactatc?accttttaat?gatccaaatt?gtgctttcat?240
tttgtgagcc?atttgtcatg?tacgagttgc?aacttcacca?atacgtccca?tagc 294
Primer sequence is:
1.5’-gctatgggacgtattggtgaa-3’
2.5’-atcccctgctacacaacgag-3’
The specific DNA sequence of above-mentioned ureaplasma (3) is used to diagnose the probe sequence of the gene chip of ureaplasma, and carries out pcr amplification by above-mentioned primer sequence, hybridizes behind the mark to detect or be directly used in the PCR diagnosis.
The employed method of setting up with the present invention of clinical detection technique has quick, accurate, easy and simple to handle, low cost and other advantages.
Description of drawings:
Fig. 1 is the pcr amplification collection of illustrative plates of clinical samples.
Fig. 2, Fig. 2 are continuous to be sequencer map.Wherein Fig. 2 be sequence, Fig. 2 of measuring continuous be the primitive sequencer collection of illustrative plates.
Fig. 3 is with the sequencing result and the comparative analysis of estimating sequence of Blast software to pcr amplification product.
Fig. 4, Fig. 4 continue (1), Fig. 4 continuous (2) is a Blast Search Results in the gene database.
Fig. 5 is the gene chip hybridization result.
Embodiment:
Be keyword at first with the ureaplasma, the nucleotide sequence of search ureaplasma in gene database.Obtain the closer nucleotide sequence of several relations altogether, with these nucleotide sequences with the nucleotide sequence (nr) in the online use software of the online Blast of the NCBI comparison gene database, discharge nonspecific nucleotide sequence, obtained the specific nucleotide sequence of 1Kb.With this section sequences Design surplus 20 to the PCR primer, extract DNA with clinical samples, carry out pcr amplification, screen a pair of sequence and the primer that is fit to carry out pcr amplification, the product that pcr amplification obtains with estimate that big or small consistent (see Fig. 1, sequence number is among the figure: 1. standard molecular weight DNA, the molecular weight size is respectively from top to bottom: 622,527,404,309,242/238,217,201,190,180,160+160,147+147,123; 2.4.5 clinical negative sample does not have amplified production; 3. clinical positive sample, amplified production is very pure, and size about 210 is consistent with the expectation size.The collection of illustrative plates result shows with the special amplification clinical sample of the energy of the primer among the present invention), clone with T-vector then, and the order-checking (sequencer address is seen Fig. 2, Fig. 2 is continuous, among the figure since 56, to 349,294bp is a cloned sequence altogether, all the other sequences are the cloning vector sequence), sequence is 294bp, estimates sequence by the comparison of Blast software, show with the sequence of estimating is consistent and (see Fig. 3, remove the 22nd among the figure, 199 and 269 become a by g, the 46th, 121,127,187,196 and 205 change over g by a, the 79th, 100,103 and 115 change over t by a, the 109th becomes g by t, the 111st becomes t by g, and the 120th and 171 becomes c by t, and the 132nd and 197 becomes t by c, the 139th, 223,232 become a by t, the 157th, 168,211 become c by a, and the 261st is become outside a by t, and all the other are all consistent with the expectation sequence), show that this sequence can be can be used for ureaplasma PCR and detect by specific amplification.Sequence is with DNA (the comprising cDNA) sequence of the Blast muca gene database of NCBI website, this sequence is only consistent with the sequence of ureaplasma, and do not have homology [to see that Fig. 4, Fig. 4 continue (1), Fig. 4 continuous (2) with other species sequence, search result shows among the figure, have only plasmid dna sequence and this sequence homology of ureaplasma, and be to match fully.And other sequence, owing to do not have primer to match with it, so in detection, can not be detected].With behind this sequence mark as probe with contain the gene chip hybridization of 45 gene locuss of 9 kinds of kinds of genitourinary infection pathogen, have only sequence of the present invention that hybridization signal is arranged therewith, and other all sequences therewith the amixia signal (see Fig. 5, be four repetitions among the figure, each repeats to contain 9 kinds of urogenital infections disease pathogen things totally 45 different sites and 4 control site.Results of hybridization shows to have only this sequence that special signal is arranged, and other equal amixia signal), show that this sequence is the distinguished sequence of ureaplasma.
The present invention can be used for the clinical detection that PCR method or method for gene chip carry out ureaplasma.Carry out pcr amplification with sequence provided by the invention, obtain product according to PCR method and whether occur judging whether to infect into ureaplasma with size.An also available sequence is a probe, as a detection site in the gene chip, then with the amplification of the PCR primer sequence among the present invention clinical samples, and hybridizes detection behind the mark.
The specification sheets sequence table
SEQUENCE?LISTING
<110〉Kunming Huanji Biochip Development Co., Ltd
<120〉segment of ureaplasma DNA sequence (3) is specific determines and application
<130>
<140>02133343.2
<141>2002-06-20
<160>1
<170>PatentIn?version?3.1
<210>1
<211>294
<212>DNA
<213〉ureaplasma (Ureaplasma urealyticum)
<220>
<221>gene
<222>(1)..(294)
<223>
<400>1
atcccctgct?acacaacgag?cgattacacc?catttttaca?acataataag?gttttgcacc 60
aaagaattta?ggttctcaag?caacaatatc?agctaattta?ccaacttcta?gtgaaccaat 120
ataagaatca?acaccatgtg?caatagctgg?gttaatcgta?tatttagaaa?tataacgttt 180
tacacgattg?ttatcactga?attcactatc?accttttaat?gatccaaatt?gtgctttcat 240
tttgtgagcc?atttgtcatg?tacgagttgc?aacttcacca?atacgtccca?tagc 294

Claims (2)

1, segment of ureaplasma DNA sequence (3) is specific determines that the length that it is characterized in that this sequence is 294bp, and sequence and PCR primer are as follows:
atcccctgct?acacaacgag?cgattacacc?catttttaca?acataataag?gttttgcacc 60
aaagaattta?ggttctcaag?caacaatatc?agctaattta?ccaacttcta?gtgaaccaat 120
ataagaatca?acaccatgtg?caatagctgg?gttaatcgta?tatttagaaa?tataacgttt 180
tacacgattg?ttatcactga?attcactatc?accttttaat?gatccaaatt?gtgctttcat 240
tttgtgagcc?atttgtcatg?tacgagttgc?aacttcacca?atacgtccca?tagc 294
Primer sequence is:
1.5’-gctatgggacgtattggtgaa-3’
2.5’-atcccctgctacacaacgag-3’
2, the specific application of segment of ureaplasma DNA sequence (3), it is characterized in that this sequence is used to diagnose the probe sequence of the gene chip of ureaplasma, and carry out pcr amplification by above-mentioned primer sequence, hybridize behind the mark and detect or be directly used in the PCR diagnosis.
CN 02133343 2002-06-20 2002-06-20 Determination of specificity for a segment of ureaplasma DNA sequence and use thereof Pending CN1572883A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02133343 CN1572883A (en) 2002-06-20 2002-06-20 Determination of specificity for a segment of ureaplasma DNA sequence and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02133343 CN1572883A (en) 2002-06-20 2002-06-20 Determination of specificity for a segment of ureaplasma DNA sequence and use thereof

Publications (1)

Publication Number Publication Date
CN1572883A true CN1572883A (en) 2005-02-02

Family

ID=34468850

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02133343 Pending CN1572883A (en) 2002-06-20 2002-06-20 Determination of specificity for a segment of ureaplasma DNA sequence and use thereof

Country Status (1)

Country Link
CN (1) CN1572883A (en)

Similar Documents

Publication Publication Date Title
CN1206367C (en) Determination of a section of mycoplasma urealyticum DNA sequence (4) specificity and its use
CN1238521C (en) Determination of a section of man-shaped mycoplasma DNA sequence (4) specificity and its use
CN1206366C (en) Determination of man-shaped mycoplasma DNA sequence (2) specificity and its use
CN1267564C (en) Determination of one section urea degraded mycoplasmos DNA sequence (5) specificity and its application
CN1205341C (en) Determination of man-shaped mycoplasma DNA sequence (5) specificity and its use
CN1570136A (en) Human type mycoplasma DNA sequence (3) specificity determination and its uses
CN1572883A (en) Determination of specificity for a segment of ureaplasma DNA sequence and use thereof
CN1168835C (en) Determination for specificity of Candida albicans DNA sequence (2) and use thereof
CN1232650C (en) Specificity determination and application of one section of gonococcus DNA sequence
CN1170945C (en) Determination for specificity of ureaplasma DNA sequence (1) and use thereof
CN1285734C (en) Determination of one section human type mycoplasmas DNA sequence (1) specificity and its application
CN1168836C (en) Determination for specificity of candida albicans DNA sequence (3) and use thereof
CN1168833C (en) Determination for specificity of candida albicans DNA sequence (4) and use thereof
CN1495265A (en) Definition of Gardner&#39;s bacillus DNA sequence (1) specificity of vagina and its application
CN1168834C (en) Determination for specificity of Candida albicans DNA sequence (5) and use thereof
CN113718053A (en) Probe and primer pair for detecting yersinia sporogenes, detection method and application
CN1493698A (en) Determination of one section vagina bacillus Gardner DNA sequence (3) specificity and its application
CN1514015A (en) Determination of one section urea degraded mycoplasmos DNA sequence (2) specificity and its application
CN1495267A (en) Definition of human papillomavirus-6 DNA sequence (4) specificity and its application
CN1495269A (en) Definition of vaginal Gardner&#39;s bacillus DNA sequence (4) specificity and its application
CN1495271A (en) Definition of human papillomavirus-6 DNA sequence (1) specificity and its application
CN1493699A (en) Determination of one section vagina bucillus Gardner DNA sequence (2) specificity and its application
CN1495264A (en) Definition of Gardner&#39;s bacillus DNA sequence (5) specificity of vagina and its application
CN1495266A (en) Definition of human papillomavirus-6 DNA squence (5) speicificity and its application
CN1495270A (en) Definition of human papillomavirus-6 DNA sequence (2) specificity and its application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication